4.7 Review

Immunoregulation with mTOR inhibitors to prevent COVID-19 severity: A novel intervention strategy beyond vaccines and specific antiviral medicines

Related references

Note: Only part of the references are listed.
Article Immunology

Is COVID-19 receiving ADE from other coronaviruses?

Jason A. Tetro

MICROBES AND INFECTION (2020)

Editorial Material Medicine, Research & Experimental

SARS-CoV-2: a storm is raging

Savannah F. Pedersen et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Multidisciplinary Sciences

Effectiveness of convalescent plasma therapy in severe COVID-19 patients

Kai Duan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Multidisciplinary Sciences

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

David E. Gordon et al.

NATURE (2020)

Article Multidisciplinary Sciences

Twenty-five years of mTOR: Uncovering the link from nutrients to growth

David M. Sabatini

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Review Immunology

Regulation of innate immune cell function by mTOR

Thomas Weichhart et al.

NATURE REVIEWS IMMUNOLOGY (2015)

Article Multidisciplinary Sciences

mTOR kinase inhibitors promote antibody class switching via mTORC2 inhibition

Jose J. Limon et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Immunology

Prevalence of Antibodies to Four Human Coronaviruses Is Lower in Nasal Secretions than in Serum

Geoffrey J. Gorse et al.

CLINICAL AND VACCINE IMMUNOLOGY (2010)

Review Surgery

The Multifunctional Role of mTOR in Innate Immunity: Implications for Transplant Immunity

M. D. Saeemann et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2009)

Editorial Material Cell Biology

mTOR signaling at a glance

Mathieu Laplante et al.

JOURNAL OF CELL SCIENCE (2009)

Article Immunology

Neutralizing antibody response and SARS severity

MS Ho et al.

EMERGING INFECTIOUS DISEASES (2005)

Article Infectious Diseases

Use of convalescent plasma therapy in SARS patients in Hong Kong

Y Cheng et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)